Midmark RTLS and Primex Anounce a New Partnership
Midmark TRLS notes this partnership will allow us to provide efficient and valuable solutions for customers through our mutual certified system integrators.
HAART 200 Aortic Annuloplasty Device: 1st European Commercialization Implantation Reported
First commercial implantations of the HAART 200 Device for Bicuspid Aortic Valve repair was performed by Professor Marek Jasinski at the Wroclaw Medical University.
Synedgen RCT Underway: Test Safety of SynPure & Catasyn
Synedgen: RCT Underway to Test Safety of SynPure and Catasyn
Synedgen, a biotechnology company using glycopolymer chemistry to develop therapeutics that enhance and control signaling...
FDA Approves New Treatment for Pompe Disease
"Pompe disease is a rare genetic disease that causes premature death and has a debilitating effect on people's lives," said Janet Maynard, M.D., deputy director of the Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine in the FDA's Center for Drug Evaluation and Research. "Today's approval brings patients with Pompe disease another enzyme replacement therapy option for this rare disease.
Paragonix Technologies Launches New OPTION On-Demand Preservation Services Network
Integrated network provides transplant programs nationwide with expedited access to advanced organ preservation and transport solutions.